In line with that: the strategic partnership with Partex (a small company nobody knows) with the 'ambition to reshape the future of the biopharma business model' with their 'disruptive ai work', to drive efficiency, effectiveness, and innovation across the value chain with patient-centric focus at every step. All buzzwords! It's ridiculous for a 300M company without a drug on the market. Even BP companies that are 1000x bigger would be more modest. Does he think he is Steve Jobs? Just get a few experienced people on board from big pharma and do your job!